Table 1. CLINICAL CHARACTERISTICS OF PATIENTS

PJ, pancreatojejunostomy; PG, pancreatogastrostomy.

* Pancreatic leakage: defined as drainage of more than 30 mL of fluid with an amylase level higher than 600 U/dL on or after postoperative week 1.

† Octreotide treatment: 7 days treatment with Sandostatin (100 μg per 8 hours) subcutaneously to treat or prevent pancreatic leakage.

‡ Adjuvant chemoradiation: 40 Gy of radiation delivered as a split course of 20 Gy in 10 fractions over 2 weeks with a 2-week break between course. 5-FU was added during day 1 through 3 of each course of radiotherapy at a dose of 500 mg/m² per day.